Cumberland Pharmaceuticals Stock Analysis

Cumberland Stock Analysis Notes

About 42.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cumberland Pharmaceuticals recorded a loss per share of 0.24. The entity last dividend was issued on the 29th of October 2010. The firm had 2:1 split on the 6th of July 2007. Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people. For more info on Cumberland Pharmaceuticals please contact the company at 615 255 0068 or go to https://www.cumberlandpharma.com.

Cumberland Pharmaceuticals Investment Alerts

Cumberland Pharmaceuticals Upcoming and Recent Events

Cumberland Largest EPS Surprises

View All Earnings Estimates

Cumberland Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Cumberland Pharmaceuticals Thematic Classifications

Cumberland Stock Institutional Investors

Note, although Cumberland Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cumberland Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.17 M.

Cumberland Profitablity

The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11.

Management Efficiency

Cumberland Pharmaceuticals has return on total asset (ROA) of (0.027) % which means that it has lost $0.027 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1186) %, meaning that it created substantial loss on money invested by shareholders. Cumberland Pharmaceuticals' management efficiency ratios could be used to measure how well Cumberland Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.11 in 2025. Return On Capital Employed is likely to rise to -0.15 in 2025. At this time, Cumberland Pharmaceuticals' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 3.2 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 28.3 M in 2025.

Technical Drivers

As of the 21st of July, Cumberland Pharmaceuticals shows the Risk Adjusted Performance of 0.0058, mean deviation of 6.36, and Standard Deviation of 8.64. Cumberland Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Cumberland Pharmaceuticals Price Movement Analysis

Cumberland Pharmaceuticals Insider Trading Activities

Cumberland Pharmaceuticals Outstanding Bonds

Cumberland Pharmaceuticals Predictive Daily Indicators

Cumberland Pharmaceuticals Forecast Models

Cumberland Pharmaceuticals' time-series forecasting models are one of many Cumberland Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cumberland Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cumberland Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cumberland shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cumberland Pharmaceuticals. By using and applying Cumberland Stock analysis, traders can create a robust methodology for identifying Cumberland entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cumberland analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cumberland analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cumberland Pharmaceuticals stock analysis indicators help investors evaluate how Cumberland Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cumberland Pharmaceuticals shares will generate the highest return on investment. By understating and applying Cumberland Pharmaceuticals stock analysis, traders can identify Cumberland Pharmaceuticals position entry and exit signals to maximize returns.

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.